Text or call us to book a same-day or next-day appointment.
Common side effects observed in monotherapy trials, similar to other GLP-1 receptor agonists, include gastrointestinal symptoms such as nausea, diarrhea, and vomiting, with most adverse events being mild to moderate in severity
In the trial, people on the Wegovy pill lost about 13.6% of their body weight, while people on a placebo lost about 2% after 71 weeks
They can increase bloating and discomfort when digestion is already slowed
Patients in their 40s and 50s using tirzepatide should realistically expect some degree of loose skin, especially if they achieve the full 15-20% weight loss potential
Escalate When It Persists Recurring symptoms despite focused changes need medical evaluation rather than a longer and more restrictive elimination list